Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Joseph Murray MD

Joseph A. Murray MD

Professor of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota

Dr. Murray studied medicine at National University of Ireland and internal medicine/gastroenterology training at Trinity College and Beaumont Hospital (Dublin) and the University of Iowa.  Dr. Murray was on the faculty of University of Iowa (1990-1998) before joining the Division of Gastroenterology at Mayo Clinic in Rochester, MN in 1998, becoming Professor of Medicine in 2004.  Dr. Murray has strong background/experience in basic/clinical gastroenterology, and his work spans basic/translational research in celiac disease focusing on immunology, genetics of the disease and immune responses to food and microbiota.  He is president of North American Society for the Study of Celiac Disease.

Disclosures

Dr. Murray reports the following: Grants from Nexpep/ImmusanT, National Institutes of Health, Immunogenix, Takeda Pharmaceutical, Allakos, ProventionBio, Oberkotter Foundation, and 9Meters, Inc.; Contract (to institution) from Kanyos Bio (a wholly owned subsidiary of Anokion); and consultancy fees from Johnson and Johnson, Bristol Myers Squibb, Intrexon Corporation, Dren Bio, Neoleukin, Reistone pharma, Immunic Therapeutics, Senda Biosciences, Brightseed Bio, Chugai Pharma, Alimentiv, Equillium, Ukko, Vial Health Technologies and has received royalties from Torax Medical and Evelo.

Recent Contributions to PracticeUpdate:

  1. Gluten-Free Diet Induces Rapid Changes in Phenotype and Survival Properties of Gluten-Specific T Cells in Celiac Disease
  2. Accuracy of the No-Biopsy Approach for the Diagnosis of Coeliac Disease in Adults
  3. Serum Anti-Tissue Transglutaminase IgA Levels and Prediction of Duodenal Villous Atrophy in Adults With Suspected Coeliac Disease Without IgA Deficiency
  4. Functional Gastrointestinal Disorders and Associated Health Impairment in Celiac Disease
  5. A Transglutaminase 2 Inhibitor for Celiac Disease
  6. Risk of Small Bowel Adenocarcinoma, Adenomas, and Carcinoids in Celiac Disease
  7. Isotretinoin Exposure and Inflammatory Bowel Disease

Most Read This Week

Recently Updated